NCM
GILD icon

Northstar Capital Management’s Gilead Sciences GILD Stock Holding History

Northstar Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$51K Hold
800
– – 0.05% 60
2019
Q2 		$54K Hold
800
– – 0.05% 58
2019
Q1 		$52K Hold
800
– – 0.05% 60
2018
Q4 		$50K Hold
800
– – 0.05% 55
2018
Q3 		$62K Sell
800
-440
-35% -$33.2K 0.05% 56
2018
Q2 		$88K Hold
1,240
– – 0.08% 48
2018
Q1 		$93K Hold
1,240
– – 0.09% 49
2017
Q4 		$89K Buy
+1,240
New +$94.2K 0.09% 54

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northstar Capital Management's GILD Position: Q3 2019 in Review

Northstar Capital Management held its Gilead Sciences (GILD) position steady in Q3 2019 at 800 shares worth $51K. The position accounts for 0.05% of the portfolio, ranked #60.

Northstar Capital Management first reported a position in GILD in Q4 2017 and has held it in 8 quarters since. The position peaked at $93K in Q1 2018. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Northstar Capital Management held 800 shares of Gilead Sciences worth $51K as of Q3 2019.
  • Northstar Capital Management left its Gilead Sciences share count unchanged in Q3 2019.
  • Gilead Sciences made up 0.05% of Northstar Capital Management's portfolio in Q3 2019, its #60 holding.
  • Northstar Capital Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 8 quarters since.
  • Northstar Capital Management's Gilead Sciences position peaked at $93K in Q1 2018.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.